Home>>Signaling Pathways>> GPCR/G protein>> Angiotensin Receptor>>A 779

A 779

Catalog No.GC11004

angiotensin-(1-7)/ Mas receptor antagonist

Products are for research use only. Not for human use. We do not sell to patients.

A 779 Chemical Structure

Cas No.: 159432-28-7

Size Price Stock Qty
1mg
$46.00
In stock
2mg Please Inquire Please Inquire
5mg
$65.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product Documents

Quality Control & SDS

View current batch:

Protocol

Animal experiment:

A bilateral OVX operation is use to induce postmenopausal osteoporosis in female Wistar albino rats. The animals are generally anesthetized using single IP injection of ketamine + xylazine combination (80 mg/kg and 5 mg/kg; respectively). After ligation, the ovaries are excised from a longitudinal incision made on the dorsolateral body region. Sham rats have the same procedure without the ligation and excision. The risk of postoperative infection is eliminated by applying fusidic acid topical antibiotic cream twice weekly for 4 weeks. Following the sham and OVX operations, animals are divided into eight groups (n = 8/group) including, Sham, Sham + Ang(1-7), Sham + A-779, Sham + Ang(1-7)+A-779, OVX, OVX + Ang(1-7), OVX + A-779 and OVX + Ang(1-7)+A-779. Eight weeks following sham and OVX operations, osmotic pumps are implanted subcutaneously to deliver Ang(1-7) (200 ng/kg/min), A-779 (400 ng/kg/min) or a mixture of Ang(1-7) and A-779 (200 ng/kg/min and 400 ng/kg/min; respectively) for 6 consecutive weeks. Body weights of all animals are monitored and recorded at the beginning and every week throughout the study. Animals' general health is maintained during periods of treatments. At the end of treatments periods, animals are placed fasting in metabolic cages for 16 hr and urine samples are collected and frozen at −70°C. Then, the blood samples are collected by cardiac puncture under ketamine + xylazine anesthesia and serum samples are obtain by centrifugation at 4000 RPM to. Animals are then sacrificed by decapitation and the uterine tissues and femoral bones are removed and cleaned. Uterine tissues are cleaned from fats and the wet weights are determined directly and expressed as g/100 g body weight. In each rat, both femurs are removed and cleaned from soft tissues. The left femoral bone samples are frozen at −70°C until analyzed, while the right femoral bones are kept in 10% formalin for mico-CT and minerals analysis.

References:

[1]. Abuohashish HM, et al. Angiotensin (1-7) ameliorates the structural and biochemical alterations of ovariectomy-induced osteoporosis in rats via activation of ACE-2/Mas receptor axis. Sci Rep. 2017 May 23;7(1):2293.
[2]. Abuohashish HM, et al. ACE-2/Ang1-7/Mas cascade mediates ACE inhibitor, captopril, protective effects in estrogen-deficient osteoporotic rats. Biomed Pharmacother. 2017 Aug;92:58-68.
[3]. Yan WF, et al. Effects and related mechanism of angiotensin-(1-7) on Toll-like receptor 4-mediated oxidative stress in human umbilical vein endothelial cells. Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Mar 24;45(3):223-229.

Background

A 779 is a potent and selective angiotensin-(1-7)/ Mas receptor antagonist [1].

Angiotensin-(1-7) is a bioactive component of the renin angiotensin system (RAS) which plays an important role in cardiovascular homeostasis and hydroelectrolyte balance in physiological and pathologic conditions [1][2].

A 779 is an angiotensin antagonist selective for the heptapeptide angiotensin-(I-7) [Ang-(l-7)] [1].

In water-loaded rats, A 779 significantly inhibited the antidiuretic effect of Ang-(l-7). In the rostral ventrolateral medulla, A-779 completely blocked the pressor effect produced by Ang-(1-7) microinjection [1]. In conscious Wistar rats, infusion of vehicle or A-779 (80 ng/ min, i.v.) started 40 to 45 minutes after captopril administration produced a significant shift of the BK dose-response curve obtained after captopril. A-779 significantly attenuated the potentiation of the hypotensive effect of BK by the ACE inhibitor captopril in conscious rats [2]. In anaesthetized male Wistar rats, when AT1R and AT2R were blocked, A779 increased renal blood flow/wet kidney tissue weight (RBF/KW). Co-blockade of all AT1R, AT2R, and MasR might alter RBF/ KW in male more than in female rats, which supported a crosstalk between MasR and Ang II receptors in renal circulation [3].

References:
Santos RA, Campagnole-Santos MJ, Baracho NC, et al.  Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors. Brain Res Bull. 1994;35(4):293-8.
Maia LG, Ramos MC, Fernandes L, et al.  Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats. J Cardiovasc Pharmacol. 2004 May;43(5):685-91.
Mansoori A, Oryan S, Nematbakhsh M.  Role of Mas receptor antagonist (A779) in renal hemodynamics in condition of blocked angiotensin II receptors in rats. Acta Physiol Hung. 2016 Mar;103(1):13-20.

Chemical Properties

Cas No. 159432-28-7 SDF
Chemical Name (2R,3Z,5S,6Z,8S,9Z,11S,12Z,14S,15Z,17S,18Z,20S)-5-((1H-imidazol-5-yl)methyl)-20-amino-8-((S)-sec-butyl)-17-(3-guanidinopropyl)-4,7,10,13,16,19-hexahydroxy-11-(4-hydroxybenzyl)-14-isopropyl-2-methyl-3,6,9,12,15,18-hexaazadocosa-3,6,9,12,15,18-hexaene-1,22-
Canonical SMILES CC[C@]([C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](N)([H])CC(O)=O)([H])CCCNC(N)=N)([H])C(C)C)([H])CC1=CC=C(O)C=C1)([H])/C(O)=N/[C@@](/C(O)=N/[C@](C(O)=O)([H])C)([H])CC2=CN=CN2)([H])C
Formula C39H60N12O11 M.Wt 872.97
Solubility ≥ 29.1mg/mL in Water with gentle warming Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 1.1455 mL 5.7276 mL 11.4551 mL
5 mM 0.2291 mL 1.1455 mL 2.291 mL
10 mM 0.1146 mL 0.5728 mL 1.1455 mL
  • Molarity Calculator

  • Dilution Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).

Calculate

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Reviews

Review for A 779

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for A 779

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.